The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Prevention of Natural Colds by Contact Prophylaxis with Intranasal Alpha2-Interferon
Abstract
We conducted a randomized, placebo-controlled, double-blind study to determine whether intranasal alpha 2-interferon could prevent respiratory illnesses in healthy contacts of ill family members. Beginning within 48 hours of the onset of illness in a family member, contacts self-administered interferon (5 X 10(6) IU) or placebo spray once daily for seven days. Respiratory illness developed during the eight-day period, starting with the second day of spraying, in 52 of 222 persons in the placebo group as compared with 32 of 226 in the interferon group (P = 0.02; efficacy, 39 percent). Among persons exposed to laboratory-documented rhinovirus colds, illness developed in 2 of 27 interferon recipients as compared with 12 of 34 placebo recipients (P = 0.02; efficacy, 79 percent). During the two-week period during and after spraying, rhinovirus colds developed in 1.3 percent of those spraying with interferon and in 15.1 percent of those spraying with placebo (P = 0.003; efficacy, 88 percent). Blood-tinged mucus or nasal mucosal bleeding or both were detected in 7.7 percent of placebo and 13.6 percent of interferon users (P = 0.04), but no evidence of cumulative nasal toxicity was found. We conclude that postexposure prophylaxis with intranasal interferon may in some cases provide an effective strategy for controlling the spread of natural colds, especially those caused by rhinoviruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of rhinoviruses and coronaviruses from 38 colds in adults
Larson, H. E., Reed, S. E., & Tyrrell, D. A. J. (1980) · Journal of Medical Virology · doi:10.1002/jmv.1890050306 · Cited by 168
Intranasal Interferon- 2, Treatment of Experimental Rhinoviral Colds
Hayden, F. G., & Gwaltney, J. M. (1984) · Journal of Infectious Diseases · doi:10.1093/infdis/150.2.174 · Cited by 109
Self-citationHiggins, P. G., Phillpotts, R. J., Scott, G. M., Wallace, J., Bernhardt, L. L., & Tyrrell, D. A. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.5.713 · Cited by 90
Cited by
Interferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,766
Jacobs, S. E., Lamson, D. M., St. George, K., & Walsh, T. J. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00077-12 · Cited by 704
Subauste, M. C., Jacoby, D. B., Richards, S. M., & Proud, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118067 · Cited by 385
Respiratory Viral Infections in Immunocompetent and Immunocompromised Persons
Couch, M., & Englund, M. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00003-x · Cited by 304
Virus-induced Airway Hyperresponsiveness and Asthma
FOLKERTS, G., BUSSE, W. W., NIJKAMP, F. P., SORKNESS, R., & GERN, J. E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9707163 · Cited by 269
Metadata
- Authors
- Hayden, F. G., Albrecht, J. K., Kaiser, D. L., & Gwaltney, J. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1986-01-09
- Volume
- 314
- Issue
- 2
- Pages
- 71-75
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2015157357
- Cited by
- 203
- References
- 3
- FWCI
- 22.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevention of Natural Colds by Contact Prophylaxis with Intranasal Alpha2-Interferon. https://app.cochat.ai/papers/10.1056/nejm198601093140202
- The paper
- Hayden, F. G., Albrecht, J. K., Kaiser, D. L., & Gwaltney, J. M. (1986). Prevention of Natural Colds by Contact Prophylaxis with Intranasal Alpha2-Interferon. New England Journal of Medicine. https://doi.org/10.1056/nejm198601093140202
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.